1. AB0467 Rapid achievement of remission with certolizumab pegol was maintained for one year: interim results from fast, a german non-interventional study in rheumatoid arthritis real life patients. (23rd January 2014) Authors: Burmester, G.; Müller-Ladner, U.; Nüsslein, H.; von Hinuber, U.; Edelmann, E.; Detert, J.; Höhle, M.; Richter, C.; Klopsch, T.; Kumke, T.; Fricke, D. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0302 Tocilizumab, DMARDS and Glucocorticoids in Rheumatoid Arthritis – Interim Analysis of the German Non-Interventional Study Ichiban. (10th June 2014) Authors: Specker, C.; Kaufmann, J.; Vollmer, M.A.; Kellner, H.; Höhle, M.; Kühne, C.; Volberg, C.; Henes, J.C.; Zinke, S.; Moosig, F.; Bohl-Bühler, M.; Sieburg, M.; Aringer, M.; Hofmann, M.W.; Hellmann, P.; Fliedner, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAT0125 Tocilizumab Achieves Rapid Reduction of Disease Activity and Has Beneficial Effects on Bone Mineral Density in Patients with Rheumatoid Arthritis – Results of A Prospective 5- Year Study. (15th July 2016) Authors: Höhle, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0235 Bone Mineral Density under Tolicizumab Therapy – Results of A Prospective 5-Year Analysis. (10th June 2014) Authors: Höhle, M.; Maas, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗